Takeda-Led COVID-19 Plasma Treatment Enters Clinical Trial With First Patient

0
16
The phase 3 trial by the group, known as the CoVIg Plasma Alliance, aims to enroll 500 adult patients from the United States, Mexico and 16 other countries, according to a statement.

LEAVE A REPLY

Please enter your comment!
Please enter your name here